Meet the 2017 Laureates: Joel Finkelstein, MD


Outstanding Clinical Investigator Award

Joel Finkelstein, MD

Joel S. Finkelstein, professor of medicine at Massachusetts General Hospital and Harvard Medical School, is the recipient of the Endocrine Society’s 2017 Clinical Investigator Award.

Dr. Finkelstein’s work has generated new concepts in endocrine physiology while providing new information that has directly changed patient care. His early work describing osteoporosis in young men with GnRH deficiency led to the discovery that peak bone mass is compromised in men with histories of delayed puberty. With Dr. Matthew Smith, he demonstrated that antiresorptive agents can prevent GnRH agonist-induced bone loss in men with prostate cancer.

He supervised a group of medical residents at MGH who found that over half of medical inpatients were vitamin D deficient, a finding that raised awareness of the public heath importance of vitamin D. He led the first randomized controlled trial demonstrating that daily teriparatide administration exerts an anabolic effect on bone in humans and later reported that bisphosphonates surprisingly attenuated teriparatide’s anabolic effect.

As an investigator with the Study of Women’s Health Across the Nation (SWAN) for nearly 25 years, he and his colleagues have characterized many of the physiologic and psychosocial changes that women experience across the menopause transition, including a comprehensive natural history of transmenopausal bone loss and the gradual decline in Anti-Mullerian Hormone levels that allows for accurate and precise predictions of the timing of the final menstrual period.

His group’s recent work has established the levels of testosterone at which the key features of male hypogonadism begin to develop, thereby providing a physiologically based definition of male hypogonadism. Additionally, his group found many of the key features of male hypogonadism are due to estrogen deficiency rather than androgen deficiency. For this body of work, the Endocrine Society is pleased to present the 2017 Laureate Award for Clinical Investigation to Dr. Joel Finkelstein.

You may also like

  • Felix Beuschlein Receives 2024 Transatlantic Alliance Award in Endocrinology 

    The Endocrine Society and the European Society of Endocrinology (ESE) are delighted to announce that they have awarded the 2024 Transatlantic Alliance Award to Professor Felix Beuschlein, MD.  Beuschlein is professor of internal medicine/endocrinology and director of the Clinic for Endocrinology, Diabetology, and Clinical Nutrition at the University Clinic Zurich in Switzerland. He received his…

  • UK Joins Horizon Europe Under New Bespoke Deal

    United Kingdom scientists will have access to the world’s largest research collaboration program, Horizon Europe, as the Prime Minister secures a bespoke deal with improved financial terms for the UK’s participation. UK researchers can now apply for grants and bid to take part in projects under the Horizon program, with certainty that the UK will…

Find more in